Onco-Innovations Announces Private Placement (2025-10-14)

▤ Summary

Onco-Innovations plans to raise up to $2 million through a non-brokered private placement of units priced at $1.40 each. Each unit includes one share and half a warrant, with warrants exercisable at $2.00 for 36 months. The company says it will use the proceeds for general corporate needs, working capital, research and development, and investor relations. The release also announces the immediate appointment of Christopher Gulka to the board of directors and notes that he replaces Graydon Bensler. Onco-Innovations describes itself as a Canadian oncology company with an exclusive worldwide license to patented solid-tumor technology.

$ Funding

▦ Linked Companies